{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:47:31Z","timestamp":1761850051634,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1080\/00313020600751069","type":"journal-article","created":{"date-parts":[[2006,5,31]],"date-time":"2006-05-31T21:52:03Z","timestamp":1149112323000},"page":"245-248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Antimicrobial drug utilisation in Dunedin Hospital, New Zealand, and its association with antimicrobial resistance"],"prefix":"10.1016","volume":"38","author":[{"given":"Jocelyn E.","family":"Livesey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoke-Fong","family":"Chiew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2001","series-title":"WHO Global Strategy for Containment of Antimicrobial Resistance","key":"10.1080\/00313020600751069_bib005"},{"key":"10.1080\/00313020600751069_bib0010","first-page":"1647","article-title":"Conference tackles overprescribing of antimicrobials","volume":"61","author":"Traynor","year":"2004","journal-title":"Am J Health Syst Pharm"},{"year":"2006","series-title":"About the ATC\/DDD System","key":"10.1080\/00313020600751069_bib0015"},{"key":"10.1080\/00313020600751069_bib0020","first-page":"S19","article-title":"State-wide surveillance of in-hospital antimicrobial utilisation in South Australia","volume":"27 (Suppl)","author":"Dollman","year":"2003","journal-title":"Commun Dis Intell"},{"key":"10.1080\/00313020600751069_bib0025","unstructured":"European Surveillance of Antimicrobial Consumption (ESAC). ESAC Project Description. http:\/\/www.esac.ua.ac.be (accessed January 2006)"},{"key":"10.1080\/00313020600751069_bib0030","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.3201\/eid1008.020694","article-title":"The role of antimicrobial use in the Aberdeen MRSA Outbreak, 1996-2000","volume":"10","author":"Monnet","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"10.1080\/00313020600751069_bib0035","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/ageing\/25.3.197","article-title":"Increase of antimicrobial resistance of faecal aerobic gram-negative bacteria in a geriatric hospital","volume":"25","author":"Leistevuo","year":"1996","journal-title":"Age Ageing"},{"key":"10.1080\/00313020600751069_bib0040","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00103-004-0804-9","article-title":"SARI: Surveillance der Antibiotika-anwendung und bakteriellen Resistenzentwicklung auf deutschen Intensivstationen","volume":"47","author":"Meyer","year":"2004","journal-title":"Bundesgesundheitsbl-Gesundheitsforsch-Gesundheitsschutz"},{"key":"10.1080\/00313020600751069_bib0045","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ijantimicag.2005.08.016","article-title":"Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan","volume":"26","author":"Hsueh","year":"2005","journal-title":"Int J Antimicrob Agents"},{"year":"2005","series-title":"CLSIM100- S15. Performance Standards for Antimicrobial Susceptibility Testing; Fifteenth Informational Supplement","key":"10.1080\/00313020600751069_bib0050"},{"key":"10.1080\/00313020600751069_bib0055","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/jac\/41.2.247","article-title":"Can susceptibility to an antimicrobial be restored by halting its use? The case of streptomycin versus Enterobacteriaceae","volume":"41","author":"Chiew","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"10.1080\/00313020600751069_bib0060","series-title":"Workshop 44-09: Monitoring and evaluating antimicrobial use in health care facilities","article-title":"Data analysis: interpretation of use in multi-hospital systems","author":"Polk","year":"2004"},{"key":"10.1080\/00313020600751069_bib0065","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1086\/422647","article-title":"Predicting hospital rates of fluoroquinolone-resistant Pseudomonas aeruginosa from fluoroquinolone use in US hospitals and their surrounding communities","volume":"39","author":"Polk","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1080\/00313020600751069_bib0070","doi-asserted-by":"crossref","first-page":"889","DOI":"10.3201\/eid1106.041335","article-title":"Fluoroquinolone-resistant Escherichia coli carriage in long-term care facility","volume":"11","author":"Maslow","year":"2005","journal-title":"Emerging Infect Dis"},{"key":"10.1080\/00313020600751069_bib0075","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/jac\/dki026","article-title":"Fluoroquinolone-resistant Pseudomonas aeruginosa: risk factors for acquisition and impact on outcomes","volume":"55","author":"Hsu","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1080\/00313020600751069_bib0080","series-title":"Control No 107","article-title":"Impact of E-Prescribing on Antibiotic Use in Australia","author":"Harvey","year":"2004"},{"key":"10.1080\/00313020600751069_bib0085","doi-asserted-by":"crossref","first-page":"455","DOI":"10.5694\/j.1326-5377.2004.tb06022.x","article-title":"Impact of an electronic antibiotic advice and approval system on antibiotic prescribing in an Australian teaching hospital","volume":"180","author":"Grayson","year":"2004","journal-title":"Med J Aust"},{"key":"10.1080\/00313020600751069_bib0090","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.3201\/eid1108.050116","article-title":"Pseudomonas aeruginosa, Staphylococcus aureus, and fluoroquinolone use","volume":"11","author":"MacDougall","year":"2005","journal-title":"Emerging Infect Dis"},{"key":"10.1080\/00313020600751069_bib0095","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0140-6736(05)70770-4","article-title":"Antibiotic use and resistance - proving the obvious","volume":"365","author":"Turnidge","year":"2005","journal-title":"Lancet"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516339435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516339435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T16:11:43Z","timestamp":1758471103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302516339435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S0031302516339435"],"URL":"https:\/\/doi.org\/10.1080\/00313020600751069","relation":{},"ISSN":["0031-3025"],"issn-type":[{"type":"print","value":"0031-3025"}],"subject":[],"published":{"date-parts":[[2006,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimicrobial drug utilisation in Dunedin Hospital, New Zealand, and its association with antimicrobial resistance","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1080\/00313020600751069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}